Birt-Hogg-Dubé Syndrome
Birt-Hogg-Dubé syndrome (ORPHA:122, OMIM:135150) is a rare genetic condition that increases the risk of kidney cancer. A widely quoted figure states that 1 in 200,000 individuals will have BHD syndrome, but the conditions is generally considered to be underdiagnosed and the true prevalence is unclear. Persons with BHD syndrome can develop:
Dermatologists and doctors working in respiratory medicine have an important role in referring for genetic testing for BHD syndrome as the manifestations of BHD syndrome in skin and lung often are present before kidney cancer develops.
A definitive diagnosis of BHD syndrome is made by the detection of a pathogenic variant in one of an individual's two copies of the FLCN gene. In a subset of individuals a clinical diagnosis of BHD syndrome can be made based on clinical criteria even if a pathogenic FLCN variant is not identified.
BHD syndrome caused by FLCN pathogenic variants is inherited in an autosomal dominant way, which means that each child of an affected person has a 50% chance to inherit the FLCN variant and thereby BHD syndrome. Persons with BHD who are planning pregnancy should be offered referral to a medical genetics specialist for information and (reproductive) counselling. Pre-implantation genetic testing and/or invasive testing in pregnancy is technically possible.
According to the Clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dubé syndrome written by ERN GENTURIS:
GeneReviews® - Birt-Hogg-Dubé Syndrome
Orphanet: Birt-Hogg-Dubé syndrome
Clinical practice guidelines |
ERN GENTURIS care pathway |
ERN GENTURIS patient journey |
ERN GENTURIS publications |
Written by ERN GENTURIS |
|||
BHD syndrome guideline - Clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dubé syndrome |
Under development |
Thematic Group 4: Other rare – predominantly malignant – genturis |
ERN GENTURIS webinars - Thematic group 4: Other rare genturis
ERN GENTURIS webinars - General
A list of healthcare providers with expertise in Thematic Group 4: Other rare - predominantly malignant - genturis can be found here.
A non-exhaustive list of patient associations for genetic tumour risk syndromes in EU member states can be found here.